FH Monoclonal Antibody(7F1)

The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy.

Introducing the FH Monoclonal Antibody (7F1), a cutting-edge product designed to revolutionize the field of immunology. This highly specialized antibody is meticulously crafted using state-of-the-art technology, ensuring exceptional quality and efficacy.

The FH Monoclonal Antibody (7F1) is derived from a single clone, guaranteeing uniformity and consistency in its performance. Its unique composition enables precise targeting and binding to the FH protein, a key component in the regulation of the complement system.

With its exceptional specificity, the FH Monoclonal Antibody (7F1) offers unparalleled accuracy in detecting and quantifying FH protein levels. This invaluable tool empowers researchers and clinicians to gain deeper insights into the intricate mechanisms of complement regulation, paving the way for groundbreaking advancements in the diagnosis and treatment of complement-related disorders.

The FH Monoclonal Antibody (7F1) is meticulously validated through rigorous testing procedures, ensuring its reliability and reproducibility. Its exceptional sensitivity allows for the detection of even trace amounts of FH protein, enabling precise and accurate measurements.

This groundbreaking product is packaged in a convenient and user-friendly format, facilitating ease of use and storage. Its long shelf life ensures prolonged usability, making it an indispensable asset in any laboratory or clinical setting.

In summary, the FH Monoclonal Antibody (7F1) is a game-changing innovation in the field of immunology. Its exceptional specificity, sensitivity, and reliability make it an invaluable tool for researchers and clinicians alike. Embrace the future of immunological research and clinical practice with the FH Monoclonal Antibody (7F1).